Bill Summary for H 647 (2015-2016)

Printer-friendly: Click to view

Summary date: 

Sep 29 2015

Bill Information:

View NCGA Bill Details2015-2016 Session
House Bill 647 (Public) Filed Monday, April 13, 2015
AN ACT AUTHORIZING HEALTH CARE PROVIDERS TO PRESCRIBE, AND PHARMACISTS TO DISPENSE, EPINEPHRINE AUTO-INJECTORS TO AUTHORIZED CHILD-SERVING ENTITIES OTHER THAN SCHOOLS FOR THE EMERGENCY TREATMENT OF ANAPHYLAXIS.
Intro. by McGrady, Avila, Stevens, Glazier.

View: All Summaries for BillTracking:

Bill summary

Senate committee substitute makes the following changes to the 2nd edition.

Amends GS 90-21.15A, concerning the emergency treatment using epinephrine auto-injectors as follows. Adds to the definition of the term authorized entity that any person, corporation, or other entity that owns or operates any entity or organization listed is considered an authorized entity. Requires that an authorized entity that acquires and stocks epinephrine auto-injectors must make a good faith effort to store the supply in accordance with the manufacturer's instructions and any additional requirements that may be established by the Department of Health and Human Services (DHHS). Clarifies that employees or agents of an authorized entity or other individuals authorized to use the auto-injectors to perform specified activities must have completed the training required by the statute. Provides that an authorized entity that chooses to acquire and stock a supply of auto-injectors must designate employees or agents to complete an anaphylaxis training program. Makes organizational changes. Requires that the online training program be offered by (1) a nationally recognized organization experienced in training laypersons in emergency health treatment, (2) an entity or individual approved by DHHS, or (3) an online training course that has been approved in another state. Clarifies that the individuals listed are immune from criminal liability and from suit in any civil action brought by any person for injuries or related damages that result from any act or omission taken under the statute. Makes conforming changes. Removes exclusion from immunity for gross negligence. Adds that nothing in the statute creates or imposes any duty, obligation, or basis for liability on any authorized entity, any employee or agent of an authorized entity, or any other individual to acquire, possess, store, make available, or administer an epinephrine auto-injector. 

Changes the effective date of the act from October 1, 2015, to December 31, 2015.